Saga Bio-Tech Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 25-05-2024
- Paid Up Capital ₹ 5.00 M
as on 25-05-2024
- Company Age 21 Year, 4 Months
- Last Filing with ROC 31 Mar 2021
- Satisfied Charges ₹ 1.40 Cr
as on 25-05-2024
- Revenue 34.94%
(FY 2020)
- Profit -79.39%
(FY 2020)
- Ebitda -802.58%
(FY 2020)
- Net Worth 36.81%
(FY 2020)
- Total Assets 52.41%
(FY 2020)
About Saga Bio-Tech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company has closed loans amounting to ₹1.40 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Aditi Banka and Abhishek Banka serve as directors at the Company.
- CIN/LLPIN
U24232WB2003PTC096758
- Company No.
096758
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Aug 2003
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Saga Bio-Tech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aditi Banka  | Additional Director | 25-Oct-2021 | Current |
| Abhishek Banka | Director | 25-Aug-2015 | Current |
Financial Performance and Corporate Structure Insights of Saga Bio-Tech.
Saga Bio-Tech Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 34.94% increase. The company also saw a substantial fall in profitability, with a 79.39% decrease in profit. The company's net worth Soared by an impressive increase of 36.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Saga Bio-Tech?
In 2019, Saga Bio-Tech had a promoter holding of 37.88% and a public holding of 62.12%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Syndicate Bank Creation Date: 26 Aug 2004 | ₹1.40 Cr | Satisfied |
How Many Employees Work at Saga Bio-Tech?
Saga Bio-Tech has a workforce of 19 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Saga Bio-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saga Bio-Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
